USANA Health Sciences - USNA Stock Forecast, Price & News

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for USANA Health Sciences in the last twelve months. There are currently 1 sell rating and 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" USNA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in USNA, but not buy additional shares or sell existing shares.
View USNA analyst ratings or view top-rated stocks.

2 Wall Street analysts have issued twelve-month price targets for USANA Health Sciences' shares. Their USNA share price forecasts range from $49.00 to $53.00. On average, they predict the company's share price to reach $51.00 in the next year. This suggests that the stock has a possible downside of 2.0%.
View analysts price targets for USNA or view top-rated stocks among Wall Street analysts.

USANA Health Sciences' stock was trading at $101.20 on January 1st, 2022. Since then, USNA stock has decreased by 48.6% and is now trading at $52.06.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 14th 2023.
View our USNA earnings forecast.

USANA Health Sciences, Inc. (NYSE:USNA) announced its quarterly earnings data on Tuesday, October, 25th. The company reported $0.78 earnings per share for the quarter, missing analysts' consensus estimates of $0.89 by $0.11. The company earned $233.30 million during the quarter, compared to analyst estimates of $247.70 million. USANA Health Sciences had a trailing twelve-month return on equity of 19.22% and a net margin of 7.41%.

USANA Health Sciences announced that its Board of Directors has approved a share repurchase plan on Tuesday, February 9th 2021, which permits the company to repurchase $150,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to reacquire up to 8.2% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company's board of directors believes its stock is undervalued.

USANA Health Sciences updated its FY 2022 earnings guidance on Tuesday, November, 1st. The company provided EPS guidance of $3.15-$3.40 for the period, compared to the consensus EPS estimate of $3.90. The company issued revenue guidance of $955.00 million-$975.00 million, compared to the consensus revenue estimate of $1.03 billion.

68 employees have rated USANA Health Sciences Chief Executive Officer Kevin Guest on Glassdoor.com. Kevin Guest has an approval rating of 99% among the company's employees. This puts Kevin Guest in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other USANA Health Sciences investors own include International Business Machines (IBM), Gilead Sciences (GILD), NVIDIA (NVDA), AT&T (T), BioMarin Pharmaceutical (BMRN), Vertex Pharmaceuticals (VRTX), AbbVie (ABBV), Walt Disney (DIS), Intuitive Surgical (ISRG) and Johnson & Johnson (JNJ).

USANA Health Sciences trades on the New York Stock Exchange (NYSE) under the ticker symbol "USNA."

USANA Health Sciences' stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (9.57%), Vanguard Group Inc. (7.71%), Renaissance Technologies LLC (6.81%), Pzena Investment Management LLC (3.76%), Dimensional Fund Advisors LP (2.93%) and State Street Corp (2.04%). Insiders that own company stock include Brent Neidig, Daniel A Macuga, Daniel A Macuga, David Mulham Mulham, Feng Peng, Frederic J Winssinger, G Doug Iiekking, Gilbert A Fuller, Gilbert A Fuller, Jim Brown, John Turman Fleming, Joshua Foukas, Kevin Guest, Myron W Wentz, Paul A Jones, Robert A Sinnott, Robert Auciaux, Timothy E Wood and Walter Noot.
View institutional ownership trends.

Shares of USNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of USNA stock can currently be purchased for approximately $52.06.

USANA Health Sciences (NYSE:USNA) has a market capitalization of $1.00 billion and generates $1.19 billion in revenue each year. The company earns $116.50 million in net income (profit) each year or $3.96 on an earnings per share basis.

The company employs 1,978 workers across the globe.

USANA Health Sciences' mailing address is 3838 West Parkway Blvd, Salt Lake City UT, 84120. The official website for the company is www.usana.com. The company can be reached via phone at (801) 954-7100, via email at investor.relations@usanainc.com, or via fax at 801-954-7300.